Table 4—

Cardiovascular outcomes and infections associated with PTD in kidney transplant recipients

Outcome and investigatorsDuration of follow-up (years)Number of patients with outcome/total number of patients (%)
RR (95% CI)
PTD presentPTD absent
Cardiovascular complications
 von Kiparski et al. (21)109/32 (28)3/32 (9.4)3 (0.98–9.6)
Myocardial infarction
 Miles et al. (17)8.53/40 (7.5)3/38 (7.9)0.95 (0.2–3.9)
Stroke
 Miles et al. (17)8.52/40 (5)1/38 (2.6)1.9 (0.4–14.2)
Severe infections requiring hospitalization
 Boudreaux et al. (8,9)16/7 (86)40/98 (40.8)1.9 (1–2.6)
 von Kiparski et al. (21)1012/32 (37.5)6/32 (18.8)2 (0.9–4.6)
Cytomegalovirus infections
 Vesco et al. (10,11)614/33 (42.4)7/33 (21.2)2 (0.96–4.3)
Fatal sepsis
 Lanerolle et al. (16)3–93/34 (8.8)1/131 (0.8)11.6 (1.7–79)
 Miles et al. (17)8.55/40 (12.5)1/38 (2.6)4.8 (0.8–30)